中外健康文摘
中外健康文摘
중외건강문적
WORLD HEALTH DIGEST
2013年
42期
86-87
,共2页
依沙吖啶%米非司酮%瘢痕子宫%引产
依沙吖啶%米非司酮%瘢痕子宮%引產
의사아정%미비사동%반흔자궁%인산
Ethacridine%Mifepristone%Uterine scar%Induction of labor
目的：探讨采用依沙吖啶、米非司酮联合应用于14-20周瘢痕子宫妊娠引产的有效性和安全性。方法：对112例14-20周中期妊娠要求引产的妇女随机分为观察组合对照组，每组各56例，观察组先给予羊膜腔穿刺注射依沙吖啶100m g，再口服米非司酮75m g12小时一次共两次。对照组单用依沙吖啶羊膜腔内注射引产，结果：观察两组产程发动时间、总产程、产后出血量、胎盘胎膜残留情况的比较，差异有统计学意义（p＜0.05）。结论：采用依沙吖啶、米非司酮联合应用于瘢痕子宫中期妊娠引产安全、有效、副作用少、值得推广。
目的：探討採用依沙吖啶、米非司酮聯閤應用于14-20週瘢痕子宮妊娠引產的有效性和安全性。方法：對112例14-20週中期妊娠要求引產的婦女隨機分為觀察組閤對照組，每組各56例，觀察組先給予羊膜腔穿刺註射依沙吖啶100m g，再口服米非司酮75m g12小時一次共兩次。對照組單用依沙吖啶羊膜腔內註射引產，結果：觀察兩組產程髮動時間、總產程、產後齣血量、胎盤胎膜殘留情況的比較，差異有統計學意義（p＜0.05）。結論：採用依沙吖啶、米非司酮聯閤應用于瘢痕子宮中期妊娠引產安全、有效、副作用少、值得推廣。
목적：탐토채용의사아정、미비사동연합응용우14-20주반흔자궁임신인산적유효성화안전성。방법：대112례14-20주중기임신요구인산적부녀수궤분위관찰조합대조조，매조각56례，관찰조선급여양막강천자주사의사아정100m g，재구복미비사동75m g12소시일차공량차。대조조단용의사아정양막강내주사인산，결과：관찰량조산정발동시간、총산정、산후출혈량、태반태막잔류정황적비교，차이유통계학의의（p＜0.05）。결론：채용의사아정、미비사동연합응용우반흔자궁중기임신인산안전、유효、부작용소、치득추엄。
Objective: To evaluate the efficacy and safety of mifepristone combined with ethacridine used in 14 - 20 weeks of uterine scar pregnancy. Methods: 112 cases of 14-20 weeks pregnancy fetus were randomly divided into observation group and control group, 56 cases in each group, the observation group give first amniocentesis injection of ethacridine 100mg, and oral mifepristone 75mg12 hours a total of two times. The control group were only treated with ethacridine intra amniotic injection, results: the observation group of two stage launch time, total labor, postpartum hemorrhage volume, retained placenta and membranes were compared, the difference was statistical y significant (P < 0.05). Conclusion: Mifepristone plus ethacridine for mid trimester uterine scar is a safe, effective, less side effect abortion method,worthy of promotion.
